Bandar Alqarni/X
Sep 29, 2025, 11:36
Bandar Alqarni: Smoflipid 20% Use in IVF Protocols
Bandar Alqarni, Pharmacist in Riyadh, shared a post on X:
“Smoflipid 20% is gaining attention for its off-label use in IVF protocols, especially in cases of Recurrent Implantation Failure (RIF) or Recurrent Pregnancy Loss (RPL).
It may help by:
- Reducing NK cell activity
- Enhancing immune tolerance
- Supporting embryo implantation
While not considered a formal treatment, it is an option in select cases after ruling out organic and chromosomal causes. Its use is under strict medical supervision, often as part of an integrated immunotherapy plan.
Always consult your fertility specialist.”
-
Jun 12, 2026, 14:37ACOG Releases 2026 Maternal Immunization Schedule for Pregnant and Postpartum Patients – SMFM
-
Jun 12, 2026, 14:15Camille Clare: Representing Obstetrics and Gynecology at the AMA House of Delegates!
-
Jun 12, 2026, 14:13Amos Grünebaum: Balancing Autonomy and Safety in Freebirth Counseling!
-
Jun 12, 2026, 14:08Marco Zaccaria: How Do Elastic Centripetal Forces Lead to Dynamic Changes in the Myometrial Free Margin as Regards Submucous Myomas?
-
Jun 12, 2026, 14:01Heghine Khachatryan: What Should We Test from a Hematology Perspective?
-
Jun 11, 2026, 15:52Surgical Management of Postpartum Haemorrhage and Manual Removal of the Placenta – RCOG
-
Jun 11, 2026, 15:48Christopher Robinson: Reverse Løvset Maneuver for Shoulder Dystocia!
-
Jun 11, 2026, 15:45AAP Supports ACOG’s Latest Vaccine Recommendations – American Academy of Pediatrics
-
Jun 11, 2026, 15:41Evidence-Based Approaches to Uncommon Early Pregnancy Complications – ISUOG